An observational study in Urinary Incontinence, sponsored by Kutahya Health Sciences University. Completed at 1 site in Turkey (Türkiye). Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-11.
Sponsored by Kutahya Health Sciences University · Observational
The prevalence of urinary incontinence and risk factors were investigated among female students studying at Kütahya Health Sciences University Faculty of Medicine.
Students who voluntarily participated in the study, had access to the online structured questionnaire distributed via a computer-based system, completed the survey in full, and were actively enrolled during the study period were included in the study.
1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.
This study's enrollment of 307 is above the median of 120 across 305 observational studies indexed under Urinary Incontinence.
Browse Urinary Incontinence studies →Kutahya Health Sciences University is the lead sponsor of 209 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Female Medical Student in Kütahya Health Sciences University
Exclusion Criteria:
Female Medical student in Kütahya Health Sciences University
Diagnostic Test: Questionnaire and Physical Exam
Participants completed the International Continence Questionnaire-Short Form (ICIQ-SF) and the Incontinence Impact Questionnaire (IIQ-7) form were completed
Prevelance of urinary incontinence
Prevelance of urinary incontinence was calculated
Time frame: 1 march 2025 - 1 may 2025
Plan to share: Undecided — The researchers have not yet decided whether to share the study protocol publicly.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kutahya Health Sciences University